Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 5
Journal homepage
3,518
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan; Correspondence[email protected]
View further author information
,
Masayoshi HarigaiDepartment of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan; View further author information
,
Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan; View further author information
,
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women?s Medical University, Shinjuku-ku, Tokyo, Japan; View further author information
,
Naoki IshiguroDepartment of Orthopedic Surgery, Nagoya University, Nagoya, Aichi, Japan; View further author information
,
Kazuhiko YamamotoDepartment of Allergy and Rheumatology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; View further author information
,
Nobuyuki MiyasakaDepartment of Medicine & Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan; View further author information
,
Takao KoikeSapporo Medical Center NTT EC, Sapporo, Japan; View further author information
,
Yoshifumi UkyoJanssen Pharmaceutical K.K., Chiyoda-ku, Tokyo, Japan; View further author information
,
Yutaka IshiiJanssen Pharmaceutical K.K., Chiyoda-ku, Tokyo, Japan; View further author information
,
Toru YoshinariMitsubishi Tanabe Pharma Corporation, Chuo-ku, Tokyo, Japan; View further author information
,
Daniel BakerJanssen Research & Development, LLC, Spring House, PA, USAView further author information
& the GO-MONO study group show all
Pages 770-779 | Received 11 Jul 2017, Accepted 31 Oct 2017, Published online: 08 Dec 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Masayoshi Harigai, Tsutomu Takeuchi, Josef S. Smolen, Kevin L. Winthrop, Atsushi Nishikawa, Terence P. Rooney, Chadi G. Saifan, Maher Issa, Yoshitaka Isaka, Naotsugu Akashi, Taeko Ishii & Yoshiya Tanaka. (2020) Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials. Modern Rheumatology 30:1, pages 36-43.
Read now

Articles from other publishers (3)

Masahiko Miyashiro, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu & Junya Masuda. (2023) A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan. Rheumatology and Therapy 10:3, pages 615-634.
Crossref
Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2022) Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial). Modern Rheumatology.
Crossref
Yoichi Kurosawa, Satoshi Ito, Shunsuke Sakai, Eriko Hasegawa, Daisuke Kobayashi, Asami Abe, Hiroshi Otani, Kiyoshi Nakazono, Akira Murasawa, Ichiei Narita & Hajime Ishikawa. (2022) Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis. Internal Medicine 61:14, pages 2117-2125.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.